Group 1 - The controlling shareholder, Suzhou Wuzhong Investment Holding Co., Ltd., holds 122,795,762 shares of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd., accounting for 17.24% of the total share capital [2] - As of the announcement date, all shares held by the controlling shareholder are under pledge, judicial marking, judicial freezing, or pending freezing status [2][3] - The company will actively and prudently address the risks associated with stock pledges and freezes [3] Group 2 - The company will further verify the situation regarding the controlling shareholder's shares being judicially frozen and marked, and will continuously monitor the resolution of debt risks [3]

Core Viewpoint - *ST Suwu (600200) is facing mandatory delisting due to four consecutive years of financial fraud and significant fund misappropriation, potentially becoming the ninth major company to be delisted for serious violations by 2025 [1][2][3] Financial Fraud - From 2020 to 2023, *ST Suwu engaged in continuous financial fraud, with profit inflation peaking at 51.65% in 2021. The total inflated profit amounted to 0.76 billion yuan, with inflated operating income and costs reaching 1.772 billion yuan and 1.695 billion yuan respectively [6][7] - The proportion of inflated profits was notably high, with over 25% of profits being fraudulent from 2021 to 2023, and 2021 seeing the highest inflation rate at 51.65% [6] Fund Misappropriation - *ST Suwu has experienced severe fund misappropriation, with the highest rate reaching 96.09% of its net assets by 2023. The non-operational fund occupation by related parties increased significantly from 1.27 billion yuan in 2020 to 16.93 billion yuan in 2023 [7][8] - By 2023, over 70% of *ST Suwu's net assets had been "emptied," with 7.69 billion yuan of misappropriated funds still outstanding [8] Disclosure Issues - The company failed to disclose a change in its actual controller for six years, which occurred in February 2018, leading to significant penalties [9] - The company and its main responsible individuals were fined a total of 30.5 million yuan, with the chairman facing the highest penalty of 15 million yuan and a 10-year market ban [9] Regulatory Environment - The new delisting regulations effective from January 1, 2025, have tightened the standards for mandatory delisting, particularly focusing on financial fraud [2][14] - Since the tightening of regulations, eight companies have already faced delisting procedures due to serious violations, indicating a trend towards stricter enforcement [14] Company Background - *ST Suwu, established in 1994 and listed in 1999, has struggled with poor performance in its core pharmaceutical and real estate businesses, leading to continuous losses from 2018 to 2023 [11] - Despite a brief recovery in 2024 due to a new product line, the company reported a net loss of 0.74 billion yuan in the first quarter of 2025 [11] Legal and Investor Protection - Following the investigation into *ST Suwu, investors have begun filing civil compensation lawsuits, supported by new measures for investor protection [15] - The introduction of advance compensation and commitments from administrative enforcement parties aims to enhance investor rights and recovery options [15]

Core Viewpoint - *ST Suwu has received an administrative penalty notice from the China Securities Regulatory Commission (CSRC), indicating that the company may face major illegal delisting due to inflated revenue, costs, and profits in its annual reports from 2020 to 2023 [2][5][7]. Summary by Relevant Sections Administrative Penalty Notice - The notice states that *ST Suwu's subsidiaries engaged in non-commercial trade activities with related companies, leading to inflated financial figures [5][7]. - The company is at risk of being delisted under the Shanghai Stock Exchange's rules due to these violations [2][10]. Financial Impact - The inflated revenue figures from 2020 to 2023 were reported as follows: - 2020: 495 million yuan (26.46%) - 2021: 469 million yuan (26.39%) - 2022: 431 million yuan (21.26%) - 2023: 377 million yuan (16.82%) [7]. - The inflated costs were: - 2020: 481 million yuan (37.08%) - 2021: 448 million yuan (35.47%) - 2022: 411 million yuan (28.40%) - 2023: 355 million yuan (20.95%) [7]. - The inflated profit figures were: - 2020: 14.58 million yuan (2.89%) - 2021: 20.27 million yuan (51.65%) - 2022: 19.92 million yuan (26.42%) - 2023: 21.22 million yuan (29.81%) [7]. Company Response and Future Actions - *ST Suwu has issued its first risk warning regarding the potential for major illegal delisting [8]. - If the company receives a formal penalty decision confirming the violations, it will apply for a trading suspension and disclose relevant information [10]. - The Shanghai Stock Exchange will issue a notice regarding the potential termination of *ST Suwu's stock listing within five trading days of the suspension [10]. Recent Financial Performance - For the year 2024, *ST Suwu reported: - Revenue of 1.599 billion yuan, a decrease of 28.64% year-on-year - Net profit attributable to shareholders of 70.48 million yuan, compared to a loss of 71.95 million yuan in 2023 [10][11].

Core Viewpoint - *ST Suwu has been found guilty of financial fraud for four consecutive years, leading to potential forced delisting due to significant violations of regulations [2][3]. Financial Misconduct - From 2020 to 2023, *ST Suwu's annual reports contained false records and significant omissions, inflating revenue by 4.95 billion, 4.69 billion, 4.31 billion, and 3.77 billion respectively, which accounted for 26.46%, 26.39%, 21.26%, and 16.82% of the reported revenue for those years [5]. - The company also inflated total profits by 14.58 million, 20.27 million, 19.92 million, and 21.22 million, representing 2.89%, 51.65%, 26.42%, and 29.81% of the total profits for the respective years [5]. Control and Disclosure Issues - *ST Suwu failed to accurately disclose its actual controller, with the reports from 2018 to 2023 incorrectly identifying Qian Qunying as the actual controller instead of Qian Qunshan, who gained control after a shareholding change in February 2018 [5]. Related Party Transactions - The company provided funds to related parties through non-commercial trade business payments, which were not disclosed in the annual reports from 2020 to 2023. The non-operating fund occupation by related parties was 127 million, 1.393 billion, 1.543 billion, and 1.693 billion, representing 6.88%, 74.2%, 84.6%, and 96.09% of the net assets for those years [6]. Regulatory Actions - The China Securities Regulatory Commission (CSRC) has decided to impose a fine of 10 million on *ST Suwu and has mandated corrective actions. The former chairman Qian Qunshan faces a total fine of 15 million, while other executives also received fines and warnings [6]. - Starting July 14, *ST Suwu's stock will be subject to a delisting risk warning due to the serious violations [6].

Group 1 - The stocks of New World Development (00200.HK) increased by 6.73% [1] - The shares of SJM Holdings (00880.HK) rose by 5.15% [1] - Wynn Macau (01128.HK) saw a gain of 4.91% in its stock price [1] - Galaxy Entertainment (00027.HK) experienced a 2.09% increase [1]

Core Viewpoint - The company Xinhecheng (002001) experienced a stock price decline of 1.36% to 21.8 yuan as of July 4, 2025, with a trading volume of 317,100 shares and a turnover of 693 million yuan [1]. Group 1: Company Operations - The liquid methionine project in partnership with Sinopec has entered the trial production phase, with mass production dependent on trial outcomes [2]. - The company emphasizes a customer-centric and market-oriented sales strategy, providing innovative and efficient solutions, showcasing its combined "hard power + soft service" capabilities [2]. Group 2: Investor Relations - The company values investor relations management and maintains communication through various channels, including field research, conference calls, and investor hotlines, aiming to convey its value proposition and listen to shareholder feedback [2]. - The company is open to suggestions from investors and is focused on creating long-term value for them [2]. Group 3: Trading Information - On July 4, the net inflow of main funds was 22.21 million yuan, while speculative funds and retail investors saw net outflows of 10.91 million yuan and 11.29 million yuan, respectively [2].

Group 1 - The stock price of *ST Suwu (600200) closed at 2.44 yuan on July 4, 2025, down 3.17% with a turnover rate of 4.71% and a trading volume of 334,700 hands, amounting to 82.78 million yuan [1] - The latest financial report for *ST Suwu shows total operating revenue of 317 million yuan for Q1 2025, a year-on-year decrease of 25.44%, and a net profit attributable to shareholders of 70.32 million yuan, down 1489.93% year-on-year [1] - The company has a current ratio of 1.477, a quick ratio of 1.426, and a debt-to-asset ratio of 54.16% [1] Group 2 - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. was established in 1994 and is primarily engaged in the pharmaceutical manufacturing industry, located in Suzhou [2] - The company has made investments in 12 enterprises and participated in 5 bidding projects, holding 47 trademark registrations and 2 patents, along with 9 administrative licenses [2]

Financial Performance - Total operating revenues increased by 10.8% to $1.232 billion in 1Q'25, compared to $1.112 billion in 1Q'24[17] - Gaming revenue increased by 12.2% to $1.024 billion in 1Q'25, compared to $913 million in 1Q'24[17] - Non-gaming revenue increased by 4.4% to $208 million in 1Q'25, compared to $199 million in 1Q'24[17] - Net income increased significantly by 4944.9% to $28 million in 1Q'25, compared to $1 million in 1Q'24[17] - Adjusted Property EBITDA increased by 14.1% to $341 million in 1Q'25, compared to $299 million in 1Q'24[17] Performance by Property - City of Dreams Macau's Adjusted EBITDA increased by 27.5% to $196 million in 1Q'25, compared to $154 million in 1Q'24[17] - Studio City's Adjusted EBITDA increased by 10.7% to $97 million in 1Q'25, compared to $88 million in 1Q'24[17] - Altira recorded a negative Adjusted EBITDA of $1 million in 1Q'25, compared to a positive $1 million in 1Q'24, a decrease of 148.3%[17] - City of Dreams Manila's Adjusted EBITDA decreased by 20.6% to $30 million in 1Q'25, compared to $38 million in 1Q'24[17] - City of Dreams Mediterranean and Other's Adjusted EBITDA increased by 10.2% to $12 million in 1Q'25, compared to $11 million in 1Q'24[17] Shareholder Returns - Approximately $4.1 billion has been returned to shareholders from 2016 to 2025 YTD in the form of dividends and share repurchases[45, 46, 47] - From January 1, 2025, to May 7, 2025, Melco repurchased 32.3 million ADSs for approximately $165 million[47]

金融界消息 截至2025年5月14日收盘，*ST苏吴（600200）报收于2.51元，下跌4.92%，换手率3.1%，成 交量22.04万手，成交金额5568.48万元。 来源：金融界 资金流向方面，今日主力资金净流出1557.82万元，占比成交额27.98%。其中，超大单净流出925.25万 元、占成交额16.62%，大单净流出632.57万元、占成交额11.36%，中单净流出流入0.31万元、占成交额 0.01%，小单净流入1557.51万元、占成交额27.97%。 天眼查商业履历信息显示，江苏吴中医药发展股份有限公司，成立于1994年，位于苏州市，是一家以从 事医药制造业为主的企业。企业注册资本71215.1832万人民币，实缴资本12279.5762万人民币。公司法 定代表人为钱群山。 通过天眼查大数据分析，江苏吴中医药发展股份有限公司共对外投资了13家企业，参与招投标项目5 次，知识产权方面有商标信息46条，专利信息2条，此外企业还拥有行政许可9个。 *ST苏吴最新一期业绩显示，截至2025一季报，公司营业总收入3.17亿元、同比减少25.44%，归属净利 润7031.79万元，同比减少1489.9 ...

Financial Performance - The company's net revenue for the year ending December 31, 2024, was HKD 36.17 billion, an increase of HKD 6.64 billion or 22.5% compared to HKD 29.53 billion for the same period in 2023[40] - Adjusted EBITDA for the year was HKD 9.03 billion, up from HKD 7.51 billion in the previous year[39] - The loss attributable to the company's owners was HKD 780 million, significantly reduced from HKD 1.74 billion in 2023[39] - Casino revenue rose by 22.2% from HKD 24,090.4 million in 2023 to HKD 29,432.3 million in 2024, with hotel room revenue increasing by 24.5% and food and beverage revenue increasing by 36.4%[106] - Total operating revenue for Melco Resorts increased to $4,640,000,000 in 2024 from $3,780,000,000 in 2023, representing a growth of 22.8%[115] - Adjusted property EBITDA for Melco Resorts reached $1,220,000,000 in 2024, up from $1,040,000,000 in 2023, marking a 17.3% increase[116] - Net income attributable to Melco Resorts was $43,500,000 in 2024, a significant recovery from a net loss of $326,900,000 in 2023[116] Strategic Expansion and Development - The company is set to launch the highly anticipated "The House of Dancing Water" show in May 2025, enhancing the tourism experience at City of Dreams[41] - The company plans to open a new casino at City of Dreams Sri Lanka in Q3 2025, expanding its brand and customer base[41] - The group anticipates the opening of City of Dreams Sri Lanka in Q3 2025, which is expected to be a light capital investment project with significant returns[59] - The group is exploring strategic options for City of Dreams Manila to optimize investments and effectively reallocate resources[59] - The group continues to invest resources to enrich its cultural, leisure, and tourism projects in Macau, including the return of the acclaimed water show "The House of Dancing Water" to enhance the tourism experience[75] Sustainability and Corporate Social Responsibility - The group has received recognition for its community initiatives, winning awards for best corporate social responsibility programs[25] - The group is committed to achieving carbon neutrality and reducing waste and water consumption as part of its sustainability goals[45] - The group made charitable contributions of approximately HKD 135.7 million in 2024, with nearly 3,600 volunteer hours contributed by employees globally[44] - The company was awarded the "ESG Best Performance Award - Merit" and "Theme Award - Merit" at the BDO ESG Awards 2024, recognizing its outstanding performance in sustainability[101] - The group won the "Best Overall Corporate Social Responsibility Program" and "Best Corporate Social Responsibility Initiative" at the IAG Academy IR Awards for its "Small Kindness, Big Love" initiative[98] Operational Improvements and Guest Experience - The gradual improvement in operations is attributed to the recovery of inbound tourists to Macau and the opening of new facilities[40] - The group is focusing on enhancing guest experiences and has introduced new entertainment facilities, including the first Dolby Cinema in Hong Kong and Macau[56] - The upgraded membership program offers exclusive benefits and personalized experiences to guests, aimed at increasing property attractiveness and foot traffic[56] - The group has implemented significant property upgrades that have improved guest satisfaction and overall financial performance[57] - The company continues to enhance guest experiences at Studio City through the addition of new facilities and attractions, including the opening of the first Dolby Cinema in Hong Kong and Macau[67] Environmental Impact - Greenhouse gas emissions increased from 17,688 MtCO2e in 2022 to 20,770 MtCO2e in 2023, and are projected to reach 28,675 MtCO2e in 2024[46] - Total energy consumption rose from 390,278 MWh in 2022 to 470,030 MWh in 2023, with a forecast of 536,449 MWh in 2024[47] - The total amount of waste generated increased from 7,680 tons in 2022 to 15,633 tons in 2023, expected to reach 20,996 tons in 2024[48] Corporate Governance and Leadership - The company emphasizes maintaining high levels of corporate governance to ensure responsible decision-making and improve transparency to shareholders[178] - The corporate governance framework is designed in accordance with applicable laws and listing rules, with regular reviews by the board of directors[179] - The board of directors consists of six members, with three executive directors and three independent non-executive directors, ensuring compliance with independence regulations[192] - The independent non-executive directors play a crucial role in maintaining financial reporting standards and safeguarding shareholder interests[198] - The company has established a code of conduct to ensure the highest ethical standards are upheld across all employees[181] Employee Development and Community Engagement - The company emphasizes the importance of talent and diversity in its workforce, aiming to create a supportive work environment[156] - The group is committed to providing training and development opportunities to enhance employee skills and performance[159] - The company continues to focus on supporting local SMEs through various initiatives, enhancing communication platforms to better understand their needs and services[100] - The company has implemented training programs for new employees to instill its culture and values, with ongoing monitoring of cultural promotion effectiveness[190] Market Performance and Recognition - The group has received eight Michelin stars across its five fine dining establishments, reaffirming its status as a leader in Macau's culinary scene[77] - The group received a record 107 stars in the 2025 Forbes Travel Guide, with 19 properties awarded five-star honors, reinforcing its leadership in the integrated resort sector in Macau and Asia[86] - The group was recognized as one of the top ten best integrated resorts in the Asia-Pacific region by Travel + Leisure in 2024[91] - The group’s City of Dreams Mediterranean won two awards at the 2024 World Luxury Hotel Awards, showcasing its growing influence in the global market[91]